Menu
Not yet recruiting NCT07032701

A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer

No phase Interventional Skin Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Best Practice, Educational Intervention, Educational Intervention, Electronic Health Record Review.
Who it may be relevant to
Registry conditions: Skin Carcinoma. Basic parameters: 19 years — 79 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Assessing the Impact of a Disposable Negative Pressure Wound Therapy Device on Surgical Wounds of the Lower Extremities Following Mohs Micrographic Surgery

Overview

This clinical trial studies whether a disposable negative pressure wound therapy (dNPWT) device, SNaP Wound Care System (Ultraportable Mechanically Powered Negative Pressure Wound Therapy) (SNaP), promotes wound healing in the lower limbs in patients that have undergone Mohs micrographic surgery (Mohs surgery) for non-melanoma skin cancer. Mohs surgery is a surgical technique used to treat skin cancer. Individual layers of cancerous tissue are removed and examined under a microscope one at a time until all cancerous tissue has been removed. It is an important part of removing skin cancer, but it often leads to soft-tissue defects and reconstructive challenges, especially in high-tension areas like the lower limbs. Typically, these wounds are managed by leaving them open and allowing them to heal from the base up or are reconstructed by transferring healthy skin from another part of the body. Negative pressure wound therapy (NPWT) is a wound dressing system that continuously or intermittently applies subatmospheric pressure to the surface of a wound to draw out fluid and promote healing. The SNaP device is a dNPWT device for lower leg wound healing designed for increased portability and ease of use outside of a hospital setting. It is a modification of traditional NPWT devices that uses springs to generate pressure, making it lighter and more user-friendly than traditional devices that rely on electrically powered pumps. This may be a more effective way to promote wound healing in the lower limbs following Mohs surgery for non-melanoma skin cancer.

Detailed description

PRIMARY OBJECTIVE:

I. To compare wound healing duration between the two groups, aiming to provide insights into the potential benefits of dNPWT for lower limb wounds in a clinical setting.

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP 1: Patients undergo dNPWT with SNaP device following standard of care (SOC) Mohs surgery and attend follow-up visits with re-application of SNaP device over 30 minutes once a week (QW), as needed until complete wound healing is achieved, for up to 12 weeks. Patients also receive education regarding SNaP device application and informational/educational SNaP device handouts on study.

GROUP 2: Patients undergo SOC wound care with non-adherent dressing following SOC Mohs surgery and attend follow-up visits with non-adherent dressing changes over 30 minutes QW, as needed until complete wound healing is achieved, for up to 12 weeks. Patients also receive education on SOC wound dressing changes on study.

After completion of study intervention, patients are followed up at week 12.

Interventions

  • Other Best Practice
    Undergo SOC non-adherent dressing wound care
  • Other Educational Intervention
    Receive SNaP education
  • Other Educational Intervention
    Receive SOC wound care education
  • Other Electronic Health Record Review
    Ancillary studies
  • Other Follow-Up Care
    Attend SNaP device follow-up visits
  • Other Follow-Up Care
    Attend SOC wound care follow-up visits
  • Other Medical Device Usage and Evaluation
    Undergo dNPWT with SNaP device
  • Procedure Negative Pressure Wound Therapy
    Undergo dNPWT with SNaP device
  • Other Photography
    Ancillary studies
  • Other Questionnaire Administration
    Ancillary studies

Primary outcome measures

  • Wound healing duration [Time frame: Up to 12 weeks]
Secondary outcome measures (4)
  • Mean time to wound closure [Time frame: Up to 12 weeks]
  • Patient satisfaction [Time frame: At 12 weeks]
  • Wound size progression [Time frame: Up to 12 weeks]
  • Cosmetic outcomes [Time frame: At 12 weeks]

Eligibility criteria

Inclusion criteria

  • Aged 19 to 79 years
  • Presenting with a lower limb wound following Mohs surgery for non-melanoma skin cancer, designated to heal by secondary intention
  • Wound size less than 13 cm x 13 cm
  • Patient capable of changing the SNAP-therapy system at home

Exclusion criteria

  • History of diabetes mellitus
  • History of venous insufficiency
  • History peripheral arterial disease
  • Chronic steroid use (defined as great than 6 weeks) within the last one year
  • History of HIV
  • History of chemotherapy use within the last one year
  • History of smoking exceeding 10 pack-years or current smoker
  • History of stroke
  • History of deep venous thrombosis
  • Active infection
  • Allergy to adhesives
  • Wounds with visible bone, tendon, ligament, nerve

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • UCLA / Jonsson Comprehensive Cancer Center — Los Angeles

Identifiers

NCT: NCT07032701 · 24-5683 · NCI-2025-03606

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗